Earnings Reports

Found 57,738 articles

• Mallinckrodt plc To Report Earnings Results For Third Quarter Of Fiscal 2018

  9/25/2018

  Mallinckrodt Pharmaceuticals announced today that it will report third quarter fiscal 2018 earnings results for the period ending Sept. 28, 2018, on Tuesday, Nov. 6, 2018.

• agilon health Achieves 20 Percent Boost In Closing Care Gaps By Using Physician And Member Incentives For Preventive Care

  9/25/2018

  Company releases its Annual Quality Outcomes Report

• WellCare to Release Third Quarter 2018 Results on October 30, 2018

  9/25/2018

  WellCare Health Plans, Inc. today announced that it will release its financial results for the third quarter 2018 on Tuesday, October 30, 2018, at approximately 6:00 a.m. EDT.

• Neogen reports first quarter results

  9/25/2018

  Neogen Corporation (Nasdaq: NEOG) announced today that net income for the first quarter of its 2019 fiscal year, which ended Aug. 31, increased 28% to $15,237,000, from the previous year's first quarter net income of $11,914,000

• DelMar Pharmaceuticals Announces Fiscal Year 2018 Annual Financial Results

  9/24/2018

  Company will host a business update conference call on September 25, 2018 at 4:30 PM Eastern Time

• Insulet to Announce Third Quarter 2018 Financial Results on November 1, 2018

  9/24/2018

  Insulet Corporation today announced plans to release its financial results for the third quarter of 2018 on November 1, 2018

• Astrotech Reports Fiscal Year 2018 Financial Results

  9/24/2018

  Astrotech Corporation reported its financial results for the fourth quarter and fiscal year ended June 30, 2018.

• IDEXX Laboratories to Release 2018 Third Quarter Financial Results

  9/24/2018

  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 third quarter financial results for Thursday, November 1 before the market opens.

• MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

  9/24/2018

  MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's Annual Report to shareholders. 

• The New York Academy of Medicine to Host Special Conversation with Four Former U.S. Surgeons General on October 15

  9/24/2018

  "America's Doctor: Reflections on Being the Surgeon General" to feature Drs. Antonia Novello, Joycelyn Elders, David Satcher, and Richard Carmona, moderated by Pfizer's Dr. Freda Lewis-Hall

• Zecotek Ships Over US$250,000 of LFS Scintillation Crystals and Announces Internal Strategic Review

  9/24/2018

  Zecotek Photonics Inc. is pleased to announce that it has shipped an additional US$250,000 worth of its patented LFS scintillation crystals from recently announced orders.

• Amneal to Report Third Quarter 2018 Results on November 7, 2018

  9/21/2018

  Amneal Pharmaceuticals, Inc. announced today that the Company will release its third quarter 2018 financial results on Wednesday, November 7, 2018, prior to the open of the U.S. financial markets.

• CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update

  9/21/2018

  CollPlant today announced financial results for the second quarter ended June 30, 2018 and provided an update on the Company's business developments.

• Advicenne Reports First-Half 2018 Results and Confirms Outlook for 2018

  9/20/2018

  Advicenne (Paris:ADVIC), a French company specializing in the development of therapeutic products for adults and children for the treatment of orphan renal and neurological diseases, today published its first-half financial results as of June 30, 2018 and confirms its operating outlook for 2018.

• Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Year Ended July 31, 2018

  9/20/2018

  In addition, during the conference call, the Company will provide financial guidance with respect to the full fiscal year ending July 31, 2019.

• Baxter to Host Third Quarter 2018 Financial Results Conference Call for Investors

  9/20/2018

  Baxter International Inc. will host a conference call to discuss its third quarter 2018 financial results on Wednesday, October 31, 2018, at 7:30 a.m. Central Time.

• TxCell announces first-half 2018 financial results and update on the proposed acquisition by Sangamo Therapeutics, Inc.

  9/20/2018

  TxCell SA today announces financial results for the first half of 2018 and provides an update on the proposed acquisition by Sangamo Therapeutics, Inc.

• Natural Alternatives International, Inc. Announces Fiscal 2018 and Q4 Results

  9/19/2018

  Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $2.9 million, or $0.41 per diluted share, on net sales of $39.2 million for the quarter ended June 30, 2018.

• Transgene Presents 2018 Half-Year Results and Business Update

  9/19/2018

  Transgene (Paris:TNG) (Euronext Paris: TNG), Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancers and infectious diseases, announces its financial results for the six-month period ended June 30, 2018, and provides an update on its clinical and preclinical portfolio.

• Poxel Reports Financial Results for the First Half 2018 and Provides Corporate Update

  9/19/2018

  POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today its results for the first half of 2018 ended June 30, 2018, and provided a corporate update.